Combined with the pleiotropic effects of inhibiting free fatty acid transport via CD36, these data provides a molecular mechanism through which amyloid-β can contribute to the nitric oxide signaling deficiencies associated with Alzheimer's disease. The gene discussed is CD36; the disease is early-onset autosomal dominant Alzheimer disease.